Material Estimates and Judgements (Details) |
12 Months Ended | |||
|---|---|---|---|---|
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2026
AUD ($)
|
Jun. 30, 2025
USD ($)
|
Jun. 30, 2024
USD ($)
|
|
| Material Estimates and Judgements [Line Items] | ||||
| Date of options are granted | Additionally, there are different rates supplied by the RBA each day dependent on the terms of the bond (2, 3, 5, 10 years). The term of the option will determine which rate is used (i.e. a 5-year term will use the 5-year bond rate). If an options term is between two terms, for example 4 years, the rate that is used is that of the lower term i.e. the 3-year bond rate. | Additionally, there are different rates supplied by the RBA each day dependent on the terms of the bond (2, 3, 5, 10 years). The term of the option will determine which rate is used (i.e. a 5-year term will use the 5-year bond rate). If an options term is between two terms, for example 4 years, the rate that is used is that of the lower term i.e. the 3-year bond rate. | ||
| Probability on clinical trial success | 1.00% | 1.00% | ||
| Reduction in time frame for completion of clinical trials | 1 year | 1 year | ||
| Milestone payment | $ 2,000,000 | |||
| Development period | 3 years | 3 years | ||
| Discount rate | 10.27% | |||
| Revenue | $ 2,767,888 | $ 2,767,888 | $ 3,633,422 | $ 299,228 |
| Cost of sales | $ 2,504,499 | 2,504,499 | $ 3,594,146 | |
| Prepayments | $ 806,410 | |||
| Bottom of Range [Member] | ||||
| Material Estimates and Judgements [Line Items] | ||||
| Ownership of the joint venture | 75.00% | |||
| Top of Range [Member] | ||||
| Material Estimates and Judgements [Line Items] | ||||
| Ownership of the joint venture | 87.50% | 87.50% | ||